Company / Assets per Share
Xenon Pharmaceuticals Inc. Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$7.99
FY2025
5-year range
$7.99 / $14.42
FY2021-FY2025
Trend
-22.0%
vs FY2024
Sector context
#114 of 210
Health Care
What the data says
At $7.99, Xenon Pharmaceuticals Inc.'s assets per share ranks #114 of 210 in the Health Care sector. Assets per Share has fluctuated over the past 10 years, ranging from $2.57 in FY2017 to $14.42 in FY2023.
Based on SEC 10-K filings.
7.99 in FY2025 with a 5-year CAGR of +7.8%.
Declined from $14.42 to $7.99 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -13.8%
- 5-Year CAGR
- +7.8%
- 10-Year CAGR
- -
Sector benchmark
#114 of 210 in Health CareTop 54% of 210This company $7.99 Sector average $353.15
▼
-97.7% below sector average
Key checks
Key Insights
- In FY2025, assets per share decreased 22.0% year-over-year.
- Ranks #114 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2023.
- Lowest assets per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.51 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.99 | -22.0% |
| FY2024 | $10.25 | -29.0% |
| FY2023 | $14.42 | +15.8% |
| FY2022 | $12.46 | -5.0% |
| FY2021 | $13.11 | +139.4% |
| FY2020 | $5.48 | -3.8% |
| FY2019 | $5.69 | -16.3% |
| FY2018 | $6.80 | +164.4% |
| FY2017 | $2.57 | -45.2% |
| FY2016 | $4.69 | +4.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026